Establishment of MURAi007-A, a human induced pluripotent stem cell line from a patient with inherited retinal dystrophy carrying compound heterozygous mutations in the PNPLA6 gene

Read full text Summarise with VIRAT
Authors: Tanida Chokpanuwat, Klodthida Yanukun, Pirut Thong-ngam, Arthaporn Khongkrapan, Alisa Tubsuwan, Tharikarn Sujirakul, Tai Chaiamarit, Kanit Bhukhai, Parith Wongkittichote, Nithi Asavapanumas
Cited by: 0
References: 3

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pathogenic variants in PNPLA6, encoding neuropathy target esterase (NTE), cause PNPLA6 disorders, characterized by chorioretinal dystrophy, hypopituitarism, and peripheral neuropathy. While defective NTE disrupts phospholipid homeostasis, the disease mechanism remains unclear. We generated the MURAi007-A human induced pluripotent stem cell (hiPSC) line from a male patient with PNPLA6 disorders using a non-integrating method. This hiPSC line demonstrates a normal karyotype and can differentiate into all three germ layers. The MURAi007-A line is a valuable model for investigating PNPLA6 disorder mechanisms and may also aid research into other retinal and neurological diseases.

Fields of Study & Subjects

Pluripotent Stem Cells Research Retinal Development and Disorders Retinal Diseases and Treatments

Publication details

Journal / source
Stem Cell Research
Volume
93
Pages
103971–103971
Publication date
21 March 2026
Language
EN